CRO Leadership, Clinical Operations, Data Sciences & Regulatory Affairs
Clinical Research & CRO
Executive Search
50+ CRO & Clinical Research Placements — with an average 74 Days time-to-placement and a 12-month candidate guarantee.
50+
CRO & Clinical Research Placements
74 Days
Avg. Time-to-Placement
90%
Offer Acceptance Rate
12 Months
Candidate Guarantee
Specialisation withinHealthcare & Life Sciences·Advancing Human Health
Clinical research and CRO (contract research organisation) services have become one of India's structural strengths in the global life-sciences value chain. India hosts Phase I–IV clinical trials for global pharma sponsors, operates among the world's largest clinical data-sciences and biostatistics operations, runs pharmacovigilance and medical-writing functions for global-top-10 sponsors, and supplies increasingly sophisticated clinical-operations leadership to the global CRO industry. Leadership hiring in the sub-sector is specialised — candidates carry credentials (PhD / MD / fellowship training), regulatory fluency (ICH-GCP, FDA, EMA, CDSCO), and operating scale (often leading 500-2000+ employee functions) that no adjacent industry produces.
Is This Your Situation?
If any of these sound familiar, you're speaking to the right practice.
→Global Top-10 CRO expanding India operations — hiring India MD alongside VP Clinical Operations and VP Data Sciences as a three-role leadership-team build inside six months.
→India-HQ CRO targeting an IPO window — hiring CEO succession alongside CFO with DRHP-drafting experience and parallel Head of Investor Relations placement.
→Specialist pharmacovigilance operator hiring a Head of Pharmacovigilance with multi-therapeutic-area case-processing experience and parallel Head of Medical Affairs placement.
→Academic medical centre reorganising its clinical trial unit — hiring a Director of Clinical Trials with combined clinical-operations, academic-research, and regulatory-liaison experience.
Our Clinical Research & CRO Track Record
Situation:
A global Top-10 CRO expanding its India operations from 1,200 to 2,500+ employees needed an India MD to own the scale-up — talent strategy, clinical-operations capability build-out, sponsor-relationship stewardship, and the parent-company governance load across a growing US, EU, and APAC sponsor portfolio.
Outcome:
Placed an India MD with prior global-CRO India leadership and subsequent India-HQ CRO CEO experience. Engagement included parallel VP Clinical Operations and VP Data Sciences placements on the same slate. India headcount crossed 2,400 within 18 months on the scale-up plan.
Situation:
A PE-held India-HQ specialty CRO focused on oncology and rare-disease clinical trials needed a CEO succession ahead of a targeted IPO window. The brief required sponsor-industry relationships, clinical-operations operating muscle, and the capital-markets fluency to take the business through DRHP drafting and public-market engagement.
Outcome:
Placed a CEO with prior CRO leadership and subsequent pharma R&D leadership experience. Search ran 108 days. Engagement included parallel CFO placement for DRHP drafting and audit committee build-out. DRHP drafting was completed within the sponsor's target window.
Situation:
A specialist pharmacovigilance operator running case-processing operations for 20+ global pharma sponsors needed a Chief Medical Officer with multi-therapeutic-area case-processing credibility, regulatory-submission fluency, and the gravitas to represent the operator in sponsor medical-advisory conversations.
Outcome:
Placed a Chief Medical Officer with prior global-pharma pharmacovigilance leadership and subsequent physician-leader CRO experience. Engagement included a parallel Head of Regulatory Affairs placement. The operator subsequently won three additional Tier-1 pharma sponsor engagements through the CMO's first 18 months.
All client details anonymised. Specific mandates available for reference under NDA upon request.
Our Clinical Research & CRO Practice
Clinical research and CRO (contract research organisation) services have become one of India's structural strengths in the global life-sciences value chain. India hosts Phase I–IV clinical trials for global pharma sponsors, operates among the world's largest clinical data-sciences and biostatistics operations, runs pharmacovigilance and medical-writing functions for global-top-10 sponsors, and supplies increasingly sophisticated clinical-operations leadership to the global CRO industry. Leadership hiring in the sub-sector is specialised — candidates carry credentials (PhD / MD / fellowship training), regulatory fluency (ICH-GCP, FDA, EMA, CDSCO), and operating scale (often leading 500-2000+ employee functions) that no adjacent industry produces.
We place leaders across global CROs with India operations, India-HQ CROs serving domestic and international sponsors, clinical-data-sciences and biostatistics outsourcing operators, pharmacovigilance and medical-writing platforms, regulatory-affairs outsourcing firms, site-management organisations (SMOs), clinical trial units at academic medical centres, and specialised research-site networks. Engagements include India MD / GM searches for global CROs, CEO and MD appointments for India-HQ CROs, VP Clinical Operations and VP Data Sciences searches, Chief Medical Officer and Chief Scientific Officer placements, and Head of Regulatory Affairs and Head of Pharmacovigilance hires.
Our practice is anchored in the understanding that clinical research is neither pharma nor healthcare services nor classical IT services — it is its own talent market with its own career templates and its own compensation structures. Candidates rarely transfer cleanly into or out of the sub-segment. We maintain specialised coverage of the CRO talent market with cross-border sourcing from US, EU, Singapore, and China-based CRO operators alongside deep India coverage.
As a specialist CEO mandates in life sciences, our practice also covers COO leadership for specialised operations, our practice also covers Healthcare & Life Sciences practice overview, and as a source for Pharmaceuticals & Biotech practice.
The Clinical Research & CRO Landscape Today
India's clinical research and CRO industry has crossed $3 billion in domestic revenue and contributes meaningfully to the global CRO market's $70+ billion size. India-based clinical-operations functions for global CROs collectively employ 150,000+ professionals; India-HQ CROs operate in Phase II–IV clinical trials across oncology, metabolic disease, infectious disease, and rare-disease therapeutic areas; clinical-data-sciences and biostatistics operations for global sponsors run out of Bengaluru, Hyderabad, Chennai, and Pune. Pharmacovigilance has emerged as a distinct sub-segment with India-based case-processing operations serving global sponsors. Medical writing has similarly consolidated. Regulatory-affairs outsourcing is a fast-growing adjacency. The regulatory and scientific operating envelope has strengthened — the New Drugs and Clinical Trials Rules 2019 have formalised India's clinical-trials framework; CDSCO's Subject Expert Committee (SEC) evaluation and the Central Drugs Standard Control Organisation's (CDSCO) approval timelines have become predictable; India's participation in global multi-regional clinical trials has grown post-2019; and FDA / EMA confidence in Indian clinical-trial data has materially improved. Leadership compensation has re-rated alongside the industry's maturation — senior CRO operators now command packages comparable to pharma-leadership peers.
Key Leadership Challenges in Clinical Research & CRO
India MD / GM searches for global CROs — leaders with parent-company governance fluency, India-operations scale experience, and the gravitas to represent India to global CRO HQs.
CEO / MD searches for India-HQ CROs — candidates fluent in clinical-operations rhythm, sponsor-relationship discipline, and the commercial nuance of CRO services.
VP Clinical Operations searches — leaders with 20+ years of clinical-trial operating experience, multi-therapeutic-area fluency, and global-sponsor client-relationship credibility.
VP / Head of Data Sciences searches — biostatistics, clinical programming, and clinical-data-management leaders with 500+ employee operating scale.
Chief Scientific Officer, Chief Medical Officer, and Head of Regulatory Affairs placements — specialised leadership roles at the interface of science, medicine, and regulation.
Head of Pharmacovigilance and Head of Medical Writing searches for specialised sub-segment operators.
What We Look For in Clinical Research & CRO Leaders
Across mandates, clinical research & cro leadership tends to cluster into a small set of archetypes. We calibrate each search against the profile your board actually needs — not the one most commonly available.
The CRO India MD
Leader who has run a global CRO's India operation at 2,000+ employee scale — fluent in parent-company governance, clinical-operations rhythm, sponsor-relationship discipline, and the cultural bridge between India delivery and global CRO HQ.
The India-HQ CRO CEO
Executive who has run an India-HQ CRO P&L — fluent in sponsor acquisition, commercial discipline of CRO services, clinical-operations scale-up, and the specific rhythm of CRO-industry M&A and capital-markets activity.
The VP Clinical Operations
Clinical-operations leader with 20+ years of trial-management experience across multiple therapeutic areas. Fluent in Phase I-IV operations, global-sponsor client management, and the operating rhythm of a 500+ employee clinical-operations function.
The VP Data Sciences
Biostatistics or clinical-data-management leader with 500+ employee operating scale, global-sponsor client-relationship credibility, and deep fluency in the data-sciences operating stack (SAS, R, CDISC standards, EDC platforms).
The Chief Medical / Scientific Officer
Physician or scientist-leader with credentials (MD / PhD / fellowship training), regulatory fluency, and the commercial-sponsor-facing credibility to represent a CRO in therapeutic-area advisory conversations with global pharma sponsors.
The Head of Regulatory Affairs
Regulatory-affairs leader with CDSCO, FDA, and EMA concurrent-fluency. Fluent in clinical-trial application submissions, safety reporting under CIOMS frameworks, DSUR preparation, and regulatory-strategy partnership with global sponsors.
Regulatory & Compensation Context
Regulatory Backdrop
Clinical research and CRO leadership operates under a specialised and heavily regulated envelope. The New Drugs and Clinical Trials Rules 2019 (NDCT) under the Central Drugs Standard Control Organisation (CDSCO) govern clinical-trial approvals, pre-clinical safety data requirements, and post-trial access obligations. ICH-GCP is the default operating framework; ICH-E6(R2) and E6(R3) implementation is standard. CDSCO's Subject Expert Committee (SEC) review process, the SUGAM portal for regulatory submissions, and the Ethics Committee registration framework under CDSCO form the core operating compliance. For international multi-regional clinical trials, FDA 21 CFR Parts 11, 50, 54, 56, 312, and the EMA Clinical Trials Regulation EU 536/2014 form the concurrent regulatory envelope. The ICMR's National Ethical Guidelines for Biomedical and Health Research Involving Human Participants apply to academic-site clinical research. The Health Ministry's Screening Committee (HMSC) clearances are required for specific sponsor-patient configurations. For pharmacovigilance operations, the Pharmacovigilance Programme of India (PvPI) framework, CIOMS reporting standards, and periodic safety update report (PSUR) / periodic benefit-risk evaluation report (PBRER) obligations are core. For listed CRO operators, SEBI LODR, R&D disclosure discipline, and the specific revenue-recognition rhythm of multi-year clinical-trial contracts are public-market operating concerns. DPDP Act applicability to clinical-trial data is a board-level data-governance conversation.
Compensation Architecture
CRO leadership compensation has re-rated materially. India MDs of global Top-10 CROs command ₹6-15 crore fixed cash, 50-100% annual bonus tied to revenue and operating-margin metrics, and parent-company equity (RSUs or PSUs) that typically contributes 30-50% of total comp. CEOs of India-HQ CROs (listed, pre-IPO, PE-held) price at ₹4-10 crore fixed with equity participation. VP Clinical Operations at scale (500+ employee function) commands ₹3-6 crore fixed. VP Data Sciences / VP Biostatistics range ₹2.5-5 crore fixed. Chief Medical / Scientific Officers at CROs price at ₹3-6 crore fixed, with a premium for therapeutic-area-specialised leaders. Heads of Regulatory Affairs command ₹2.5-5 crore fixed with a premium for concurrent FDA / EMA / CDSCO fluency. Heads of Pharmacovigilance range ₹2-4 crore fixed. Heads of Medical Writing price at ₹1.5-3 crore fixed. Independent directors on listed CRO boards are compensated at ₹40-75 lakh per year in cash plus committee-chair premiums. Retention for senior CRO leadership is a specific challenge — competing offers from global Top-10 CROs, pharma sponsors, and emerging specialised operators are routine; we advise clients on refresher grants, global-scope expansion, and physician-scientist-specific recognition levers alongside initial hire.
Roles We Typically Place
Why Gladwin International Leadership Advisors for Clinical Research & CRO
India MD / GM searches for global CROs — including full leadership-team build-outs for CROs expanding India operations.
CEO, MD, COO searches for India-HQ CROs (PE-held, founder-led, and subsidiary-of-pharma).
VP Clinical Operations, VP Clinical Data Sciences, VP Biostatistics placements.
Chief Medical Officer, Chief Scientific Officer, and Head of Regulatory Affairs searches.
Head of Pharmacovigilance, Head of Medical Writing, and Head of Regulatory Writing placements.
Site-management organisation (SMO) leadership and specialised research-site network leadership.
Independent director and board-chair searches for listed and pre-IPO CRO operators.
Organisations We Serve
Global Top-10 CROs with India operations
India-HQ CROs (PE-held, founder-led, pharma subsidiaries)
Clinical-data-sciences and biostatistics outsourcing operators
Pharmacovigilance and medical-writing specialist operators
Regulatory-affairs outsourcing firms
Site-management organisations and research-site networks
Academic medical centre clinical trial units
Clinical Research & CRO leaders assessed on the Healthcare “VITALIS” framework
Seven dimensions calibrated for healthcare and life sciences leadership. Dimensions are calibrated for clinical research & cro mandates where relevant.
Parent Practice
Return to Healthcare & Life Sciences
Discuss a Clinical Research & CRO Mandate
Confidential · No obligation
Response within 4 business hours · All enquiries handled by a senior practice partner · Strictly confidential